CRP and familial Mediterranean fever: In the present study, patients with homozygous/compound heterozygous or heterozygous mutations in exon 10 had significantly higher median CRP and PVAS, gastrointestinal tract involvement rate, and need for intensive treatment compared to IgAV patients without FMF.